Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Lidocaine × Thoracic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 7 UNKNOWN 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 38 Carboplatin 38 Paclitaxel 32 Radiotherapy 29 Docetaxel 17 Etoposide 16 Pemetrexed 15 Gemcitabine 15 Bevacizumab 10 Radiosurgery 9 Magnetic Resonance Spectroscopy 8 durvalumab 7 Taxes 7 Ramucirumab 6 Erlotinib Hydrochloride 6 Cetuximab 6 pembrolizumab 5 Specimen Handling 5 Irinotecan 5 Gene Expression Profiling 5 Filgrastim 5 cediranib 4 Vinorelbine 4 Polymerase Chain Reaction 4 Neoadjuvant Therapy 4 Chemotherapy, Adjuvant 4 Amplified Fragment Length Polymorphism Analysis 4 tremelimumab 3 osimertinib 3 Watchful Waiting 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07347977 2026-01-16

LidCRM

First Affiliated Hospital of Ningbo University

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡